Wael Hafez, Asrar Rashid, Hesham Mohamed Abuelsaoud, Mohan Jose, Samy Kishk, Muneir Gador, Tesfalidet Emoshe, Fatema Abdulaal, Nivedita Nair, Muhammad Ahmad, Vanya Jalal Rashid, Youmna Faheem, Steffi John, Sabah Ahmed, Ahmed Daraghmi, Rami Soliman, Ahmed Abdelrahman, Ahmed Ali Mohamed, Mirvat Ghanem
Obesity and low enzyme A disintegrin and metalloproteinase with thrombospondin type-1 motif-13 (ADAMTS13) activity have been linked to poor coronavirus disease 2019 (COVID-19). Given that obesity may influence ADAMTS13 activity, it is feasible; however, it remains unclear whether ADAMTS13 activity acts as a mediator between obesity and COVID-19 outcomes. We investigated the link between body mass index (BMI) and COVID-19 outcomes, using ADAMTS13 activity as a mediator. ADAMTS13 activity was measured in 86 hospitalized COVID-19 patients...
April 12, 2024: Medicine (Baltimore)